Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Hypersensitivity Reaction

  Free Subscription


2 Allergy
7 Allergy Asthma Proc
3 Chest
1 Clin Immunol
3 Contact Dermatitis
1 Dermatology
1 Eur J Dermatol
1 Eur Respir J
2 Int Arch Allergy Immunol
13 J Allergy Clin Immunol
3 J Invest Dermatol
1 Pediatr Dermatol
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. SHILOVSKIY I, Nikonova A, Ekaterina B, Mariya K, et al
    Anti-inflammatory effect of siRNAs targeted il-4 and il-13 in a mouse model of allergic rhinitis.
    Allergy. 2022 May 11. doi: 10.1111/all.15366.

  2. ANVARI S, Brunner S, Tuano K, Su BB, et al
    Similar IgE Binding Patterns in Gulf of Mexico and Southeast Asian Shrimp Species in US Shrimp Allergic Patients.
    Allergy. 2022 May 7. doi: 10.1111/all.15363.

    Allergy Asthma Proc

  3. BEYAZ S, Ersoy Y, Bicki E, Ak T, et al
    Psychiatric comorbidity and quality of life in patients with drug hypersensitivity.
    Allergy Asthma Proc. 2022;43:234-242.
    PubMed         Abstract available

  4. BELLANTI JA, Settipane RA
    Eosinophilic esophagitis: from discovery to effective treatment.
    Allergy Asthma Proc. 2022;43:175-177.

  5. CRAIG T, Feuersenger H, Pragst I, Dang J, et al
    Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema.
    Allergy Asthma Proc. 2022;43:202-208.
    PubMed         Abstract available

  6. SHER ER, Ross JA, Weine DM, Chandini Arjun A, et al
    Current and emerging therapies for eosinophilic esophagitis.
    Allergy Asthma Proc. 2022;43:178-186.
    PubMed         Abstract available

  7. LANG A, Balmert LC, Weiss M, Pongracic JA, et al
    Real world use of peanut component testing among children in the Chicago metropolitan area.
    Allergy Asthma Proc. 2022;43:226-233.
    PubMed         Abstract available

  8. CAN BOSTAN O, Cakmak ME, Kaya SB, Tuncay G, et al
    The association of timothy grass allergy and cat ownership on cat sensitization.
    Allergy Asthma Proc. 2022;43:220-225.
    PubMed         Abstract available

  9. DENG SJ, Wang J, Liu L, Zhang X, et al
    Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes.
    Allergy Asthma Proc. 2022;43:209-219.
    PubMed         Abstract available


  10. JOHN C, Guyatt AL, Shrine N, Packer R, et al
    Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap.
    Chest. 2022 Jan 29. pii: S0012-3692(22)00198-2. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

  11. HUDLER AC, Sharma S
    Understanding the Genetics of Asthma-COPD Overlap.
    Chest. 2022;161:1125-1126.

  12. SINGH J, Randev S, Kumar P, Mahajan V, et al
    A 16-Year-Old-Girl With Asthma, Palpable Purpura, and Hypereosinophilia.
    Chest. 2022;161:e305-e308.
    PubMed         Abstract available

    Clin Immunol

  13. SHANG W, Wang G, Wang Y, Han D, et al
    The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis.
    Clin Immunol. 2022;236:108960.
    PubMed         Abstract available

    Contact Dermatitis

  14. BROCKOW K, K R, C K, Biedermann T, et al
    Wheat-dependent exercise-induced anaphylaxis caused by percutaneous sensitisation to hydrolysed wheat protein in cosmetics.
    Contact Dermatitis. 2022 May 7. doi: 10.1111/cod.14144.

  15. GOLLER M, Dickel H, Nicolay JP
    A case of immediate type allergy from polypropylene in a particle filter mask in a nurse.
    Contact Dermatitis. 2022 May 6. doi: 10.1111/cod.14143.

  16. CLARK E, Nilsson U, Samaran Q, Raison-Peyron N, et al
    Allergic contact dermatitis from cannabis sativa (hemp) seed oil.
    Contact Dermatitis. 2022 May 5. doi: 10.1111/cod.14142.


  17. SAHIN U, Reeve K, Tochtermann G, Kilanowski K, et al
    HautTief Multidisciplinary Educational Program for Patients with Psoriasis or Atopic Dermatitis: A Randomized Controlled Study.
    Dermatology. 2022 May 9:1-10. doi: 10.1159/000524225.
    PubMed         Abstract available

    Eur J Dermatol

  18. ESCURE G, Nudel M, Terriou L, Farhat MM, et al
    Tolerance of bradykinin-releasing drugs in patients with acquired C1 inhibitor deficiency: a case series and review of the literature.
    Eur J Dermatol. 2022;32:49-55.

    Eur Respir J

  19. BATEMAN ED, Price DB, Wang HC, Khattab A, et al
    Short-acting beta2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
    Eur Respir J. 2021 Sep 24. pii: 13993003.01402-2021.
    PubMed         Abstract available

    Int Arch Allergy Immunol

  20. NAGATA S, Ohbe H, Jo T, Matsui H, et al
    Glucocorticoids and Rates of Biphasic Reactions in Patients with Adrenaline-Treated Anaphylaxis: A Propensity Score Matching Analysis.
    Int Arch Allergy Immunol. 2022 May 6:1-7. doi: 10.1159/000524612.
    PubMed         Abstract available

  21. MAKITA E, Sugawara D, Kuroda S, Itabashi K, et al
    Differences in Thymus and Activation-Regulated Chemokine and Squamous Cell Carcinoma Antigen 2 Levels in Food Protein-Induced Enterocolitis Syndrome and Atopic Dermatitis.
    Int Arch Allergy Immunol. 2022 May 10:1-8. doi: 10.1159/000524683.
    PubMed         Abstract available

    J Allergy Clin Immunol

  22. REDMOND C, Akinoso-Imran AQ, Heaney LG, Sheikh A, et al
    Socioeconomic disparities in asthma healthcare utilization, exacerbations and mortality: A systematic review and meta-analysis.
    J Allergy Clin Immunol. 2021 Oct 18. pii: S0091-6749(21)01560.
    PubMed         Abstract available

  23. HURRELL BP, Helou DG, Shafiei-Jahani P, Howard E, et al
    Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
    J Allergy Clin Immunol. 2022;149:1628-1642.
    PubMed         Abstract available

  24. SCHMALZ S, Mayr V, Shosherova A, Gepp B, et al
    Isotype-specific binding patterns of serum antibodies to multiple conformational epitopes of Bet v 1.
    J Allergy Clin Immunol. 2022;149:1786-1794.
    PubMed         Abstract available

  25. MARCHALOT A, Horiot C, Lambert JM, Carrion C, et al
    Targeting IgE polyadenylation signal with antisense oligonucleotides decreases IgE secretion and plasma cell viability.
    J Allergy Clin Immunol. 2022;149:1795-1801.
    PubMed         Abstract available

  26. BERDNIKOVS S, Newcomb DC, Gebretsadik T, Snyder BM, et al
    Cellular and systemic energy metabolic dysregulation in asthma development- a hypothesis-generating approach.
    J Allergy Clin Immunol. 2021 Nov 2. pii: S0091-6749(21)01682.
    PubMed         Abstract available

  27. JOHNSON RK, Brunetti T, Quinn K, Doenges K, et al
    Discovering metabolite quantitative trait loci in asthma using an isolated population.
    J Allergy Clin Immunol. 2021 Nov 12. pii: S0091-6749(21)01692.
    PubMed         Abstract available

  28. BAI Y, Guedes AGP, Krishnan R, Ai X, et al
    CD38 plays an age-related role in cholinergic deregulation of airway smooth muscle contractility.
    J Allergy Clin Immunol. 2022;149:1643-1654.
    PubMed         Abstract available

  29. ALTRICHTER S, Staubach P, Pasha M, Singh B, et al
    An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.
    J Allergy Clin Immunol. 2022;149:1683-1690.
    PubMed         Abstract available

  30. BACHERT C, Sousa AR, Han JK, Schlosser RJ, et al
    Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.
    J Allergy Clin Immunol. 2022;149:1711-1721.
    PubMed         Abstract available

  31. GEVAERT P, Bachert C, Maspero JF, Cuevas M, et al
    Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER).
    J Allergy Clin Immunol. 2022 Jan 27. pii: S0091-6749(21)02599.
    PubMed         Abstract available

  32. BUSSE WW, Gern JE
    Weaving innate lymphoid cells (ILC) into the fabric of asthma exacerbations.
    J Allergy Clin Immunol. 2022 Feb 8. pii: S0091-6749(22)00147.

  33. PUZZOVIO PG, Eliashar R, Levi-Schaffer F
    Tezepelumab administration in moderate-to-severe uncontrolled asthma: is it all about eosinophils?
    J Allergy Clin Immunol. 2022 Feb 8. pii: S0091-6749(22)00145.

    Fevipiprant in CRSwNP and comorbid asthma: Wrong target population or wrong PGD2 receptor?
    J Allergy Clin Immunol. 2022 Mar 15. pii: S0091-6749(22)00298.

    J Invest Dermatol

  35. GATTINGER P, Huang HJ, Valenta R, Vrtala S, et al
    Response to Gonzalez-Perez et al.
    J Invest Dermatol. 2022;142.

  36. BROWN SJ
    Atopic Eczema: How Genetic Studies Can Contribute to the Understanding of this Complex Trait.
    J Invest Dermatol. 2022;142:1015-1019.
    PubMed         Abstract available

  37. MIZUKAWA Y, Aoyama Y, Takahashi H, Takahashi R, et al
    Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification.
    J Invest Dermatol. 2022;142.
    PubMed         Abstract available

    Pediatr Dermatol

  38. CROCE EA, Rathouz PJ, Lopes FCPS, Leszczynska M, et al
    Validation of remote atopic dermatitis severity assessment with the Eczema Area and Severity Ondex in children using caregiver-provided photos and videos.
    Pediatr Dermatol. 2022 May 6. doi: 10.1111/pde.15003.
    PubMed         Abstract available

    PLoS One

  39. YOKOMICHI H, Mochizuki M, Shinohara R, Kushima M, et al
    Association of the incidence of atopic dermatitis until 3 years old with climate conditions in the first 6 months of life: Japan Environment and Children's Study (JECS).
    PLoS One. 2022;17:e0268204.
    PubMed         Abstract available

  40. FUTAMURA M, Hiramitsu Y, Kamioka N, Yamaguchi C, et al
    Prevalence of infantile wheezing and eczema in a metropolitan city in Japan: A complete census survey.
    PLoS One. 2022;17:e0268092.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.